Related Experiment Video
Updated: May 12, 2026

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
Trichomoniasis and HIV interactions: a review
Patricia Kissinger1, Alys Adamski
1Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana 70012, USA. kissing@tulane.edu
Trichomonas vaginalis (TV) significantly increases HIV acquisition and transmission. Treating TV in women with HIV reduces HIV shedding, and prevention strategies are similar for all individuals.
Area of Science:
- Infectious Diseases
- Public Health
- Epidemiology
Background:
- Trichomonas vaginalis (TV) is a common sexually transmitted infection.
- Human Immunodeficiency Virus (HIV) is a global health concern.
- Co-infection with TV and HIV presents unique challenges in management and prevention.
Purpose of the Study:
- To review the epidemiology of TV and HIV co-infections.
- To examine the role of TV in HIV acquisition and transmission.
- To discuss treatment and prevention strategies for TV in individuals with HIV.
Main Methods:
- A systematic review of the literature was conducted.
- Databases searched included EMBASE and PubMed from January 1990 to February 2013.
- Keywords focused on TV, HIV co-infections, acquisition, transmission, shedding, treatment, and couples studies.
Main Results:
- Strong evidence indicates TV increases HIV transmission and acquisition in women.
- Successful TV treatment can reduce HIV genital shedding.
- Single-dose metronidazole may be less effective for TV in HIV-positive women due to co-infections.
Conclusions:
- TV treatment in women with HIV can reduce HIV shedding.
- Prevention of TV in HIV-positive individuals involves condom promotion, screening, and prompt treatment.
- Vigilant screening and treatment of TV are crucial public health strategies for both HIV-susceptible and HIV-positive populations.
More Related Videos
Related Concept Videos
Sexually Transmitted Infections
Microbial Interactions: Parasitism
Therapeutic Drug Monitoring: Affecting Factors
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Retrovirus Life Cycles
Pharmacokinetics: Drug–Drug Interactions

